Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Graft Versus Host Disease in Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06722235
What this trial is testing

Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Takeda 171
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Post-approval studies (Phase 4)Study completedNCT00932113
What this trial is testing

Mechanism of Action Study for Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 33
Early research (Phase 1)Active Not RecruitingNCT04013685
What this trial is testing

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+3 more
Orca Biosystems, Inc. 155
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableStudy completedNCT05260255
What this trial is testing

Effect of Vitamin D Supplement on Disease Activity in SLE

Who this might be right for
Vitamin D DeficiencyHypocalcemiaHyperparathyroidism+1 more
Department of Medical Services Ministry of Public Health of Thailand 100
Not applicableUnknownNCT03170076
What this trial is testing

Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs

Who this might be right for
Hepatitis C, Chronic
Assiut University 1
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Large-scale testing (Phase 3)Active Not RecruitingNCT05677451
What this trial is testing

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 100
Not applicableLooking for participantsNCT02652169
What this trial is testing

PRF With Topical Antibiotics or Antiseptics in Chronical Wounds Version 1.4

Who this might be right for
Chronic Skin Ulcer
Medical University of Vienna 120
Not applicableUnknownNCT02209662
What this trial is testing

Safety and Efficacy Study of APIC-PRP in Non-healing Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Ulcer
Cytonics Corporation 274
Testing effectiveness (Phase 2)Study completedNCT00504270
What this trial is testing

R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Who this might be right for
Psoriasis
Hoffmann-La Roche 66
Large-scale testing (Phase 3)Active Not RecruitingNCT05513001
What this trial is testing

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 696
Testing effectiveness (Phase 2)UnknownNCT04667416
What this trial is testing

Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities

Who this might be right for
Chronic Ulcer of Lower Extremity
Amnio Technology, LLC 82
Not applicableWithdrawnNCT02492048
What this trial is testing

Effectiveness of CelluTome Epidermal Harvesting System in Autologous Skin Grafting of Chronic Wound Patients

Who this might be right for
Wounds and Injuries
LifeBridge Health
Large-scale testing (Phase 3)Active Not RecruitingNCT05976243
What this trial is testing

Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Inducible Urticaria
Novartis Pharmaceuticals 362
Not applicableNot Yet RecruitingNCT07557888
What this trial is testing

A Prospective, Single-centre, Observational Cohort Study on the Efficacy and Safety of Bacterial Lysate (OM-85) in Combination With Antihistamines for the Treatment of Chronic Spontaneous Urticaria (CSU)

Who this might be right for
Chronic Spontaneous Urticaria (CSU)
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 132
Large-scale testing (Phase 3)Ended earlyNCT00060996
What this trial is testing

Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures

Who this might be right for
Critical Limb IschemiaPeripheral Vascular DiseaseFoot Ulcers+1 more
United Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT00094562
What this trial is testing

A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss

Who this might be right for
CancerCancer CachexiaChronic Obstructive Pulmonary Disease+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Large-scale testing (Phase 3)Study completedNCT02296424
What this trial is testing

SS-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (SJIA)
Novartis Pharmaceuticals 182
Next Page